They have been slow to market but now have Immune Boost bar, Cinnergen and a cream for sores based on Cinnergen. Cinnergen is directed at Diabetic population being a natural substitute for insulin apparently.

Dupont is apparently testing an ag product called Oraphyte, a nematode control product. If this is succesful the stock will move.

I believe the downside risk is minimal here.

brew